Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FSXN4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,768
Award facts
- Contract value 100% obligated
- $1,768.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $1,768.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp (parent company: Cencora, Inc.) on January 6, 2026, for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units). This is a non-set-aside, competitively awarded contract with a completion date of January 7, 2026, and performance at the awardee's Conshohocken, Pennsylvania facility. The delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
TRELEGY ELLIPTA is a combination respiratory medication used for chronic obstructive pulmonary disease management, representing one of many pharmaceutical products delivered under the comprehensive DLA Medical Supply Chain contract. AmerisourceBergen's role as a critical pharmaceutical distributor enables it to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions. This award reflects the company's established capability to meet federal procurement requirements through open competition and efficient fulfillment of essential medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FSXN4?
SPE2DR26FSXN4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FSXN4 worth?
The government has obligated $1,768 on SPE2DR26FSXN4.
Is contract SPE2DR26FSXN4 an order under another contract?
Yes. SPE2DR26FSXN4 is a delivery order under SPE2DR25D1004, an indefinite delivery contract.
Was contract SPE2DR26FSXN4 competed?
The extent of competition for SPE2DR26FSXN4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award